Zeevat, Florian http://orcid.org/0000-0001-6427-4172
Simons, Joost J. M. http://orcid.org/0000-0001-6656-4472
Westra, Tjalke A. http://orcid.org/0000-0001-5944-5993
Wilschut, Jan C. http://orcid.org/0000-0002-3972-9697
van Sorge, Nina M. http://orcid.org/0000-0002-2695-5863
Boersma, Cornelis http://orcid.org/0000-0002-1190-2638
Postma, Maarten J. http://orcid.org/0000-0002-6306-3653
Funding for this research was provided by:
GlaxoSmithKline Biologicals
Article History
Received: 3 August 2023
Accepted: 5 December 2023
First Online: 16 February 2024
Declarations
:
: Joost J. M. Simons and Tjalke A. Westra are employed by and hold shares in GSK. Florian Zeevat reports grants from GSK for the conduct of the study via her institution (UMCG/RUG). Florian Zeevat also reports a grant from Health-Ecore and travel fees from GSK, outside the submitted work. Jan C. Wilschut reports consulting fees for advisory boards from Sanofi Pasteur and Janssen and payment from GSK for report writing outside the submitted work. Jan C. Wilschut also holds shares in Arbutus Corporation, Mymetics Corporation and ViciniVax Holding. Nina M. van Sorge declares consulting fees for service directly paid to her institution from MSD, outside the submitted work. Nina M. van Sorge also declares grants from Dutch Health Counsel, NIH and Amsterdam UMC and holds patent related to development of a vaccine against <i>Streptococcus pyogenes</i>, and for advisory board with the ItsME foundation (no honorarium) and the Rapua te me ngaro ka tau (honorarium paid to her institution), outside the submitted work. Nina M. van Sorge also holds share in Genmab BV. Cornelis Boersma reports funding from GSK to complete the work disclosed in this manuscript. Cornelis Boersma also receives consulting fees, payment and travel fees paid to his institution from various medical and pharmaceutical companies and has board membership with Netherlands Antibiotic Development Platform, ParkinsonNL, Veroz, Sustainable Health Accelerator and WAAH! Accelerator. Cornelis Boersma also holds shares in Health-Ecore, Digital Health Link, SensUR Health and Pitts. Maarten J. Postma holds shares in Health-Ecore and Pharmacoeconomics Advice Groningen Ltd. The authors declare no other financial and non-financial relationships and activities.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.